Nigam H. Shah
appointed Dr. Nigam H. Shah to the Board as a Class III director to fill the resulting vacancy.
Highest-materiality recent filing
BrightSpring appoints Dr. Nigam H. Shah to Board of Directors, effective June 11, 2026
Board expanded from 7 to 8; Dr. Shah appointed as Class III director and member of Quality and Compliance Committee.
BrightSpring sells 15M shares at $58.75 via secondary offering; KKR selling, Company buys 1M shares
Secondary offering of 14,999,771 shares of common stock at $58.75 per share; closed June 5, 2026.
Olivia Kirtley, Max Lin, and Steve Miller elected as Class II directors; each received ~155M to ~139M votes FOR.
BrightSpring Q1 revenue up 26% to $3.6B; raises FY 2026 EBITDA guidance to $795M-$825M
Net income $74M vs $9M a year ago; Adjusted EBITDA $190M, up 45% YoY from $131M.
BrightSpring completes $835M sale of ResCare Community Living to Sevita; pays down $425M debt
Closed sale of ResCare Community Living to Sevita for $835M cash (subject to working capital adjustments) on March 30, 2026.
All 20,000,000 shares sold by Selling Stockholders (KKR and management) at $41.15 per share; company received no proceeds except from option exercises.
BrightSpring Q4 revenue up 29% to $3.55B; net income $49.6M; guides 2026 EBITDA $760-790M
Q4 net revenue $3,551M (+29.3% YoY); net income $49.6M vs $4.3M; Adjusted EBITDA $184M (+40.7%).
BrightSpring Q3 revenue up 28% to $3.33B; net income $37.5M; raises FY guidance
Revenue $3,334M (+28.2% YoY); net income $37.5M vs loss $25.7M in Q3 2024.
15,000,000 shares sold by Selling Stockholders including KKR Phoenix Aggregator L.P. and management selling stockholders.
BrightSpring Q3 prelim rev up 28% YoY; raises FY 2025 guidance
Preliminary Q3 revenue ~$3,334M (+28.2% YoY); net income $37.5M vs loss $25.7M.
BrightSpring Q2 revenue $3.15B (+29% YoY); Adj. EBITDA $143M (+29%); raises FY2025 guidance
Net revenue $3,148M (+29.1% YoY); net income from cont. ops $8.5M (flat YoY).
President of Hospice Services Mike McMaude resigns; becomes consultant through Jan 2027
Michael McMaude resigned as President of Hospice Services and CEO of Abode Healthcare effective June 20, 2025; no disagreement cited.
BrightSpring Health completes 14M share secondary offering at $21.75 by KKR and management
14,000,000 shares of common stock sold by KKR Phoenix Aggregator L.P. and management stockholders at $21.75/share.
BrightSpring files 8-K with XBRL financial data; no press release provided
Filing contains XBRL-tagged annual financial data for FY2024.
BrightSpring Health Services announces 2025 Annual Meeting results; all proposals approved
Johnny Kim and Timothy A. Wicks elected as Class I directors for terms ending in 2028.
BrightSpring Q1 revenue $2,878M (+26%), net income $9.2M; raises FY 2025 guidance
Net revenue $2,878M, up 25.9% YoY; Pharmacy Solutions $2,532M (+28%), Provider Services $346M (+12%).
Mattingly receives base salary continuation through April 2026, plus 18 months COBRA premiums.
BrightSpring Q4 revenue up 29%; narrows net loss to $15.4M; raises FY25 guidance
Q4 net revenue $3,053M (+28.6% YoY); net income $15.4M vs loss $7.2M in Q4 2023.
BrightSpring promotes Jennifer Phipps to CFO effective March 4, 2025
Jennifer Phipps, previously CAO, succeeds Jim Mattingly as CFO; Mattingly's departure not due to disagreement.
Divestiture of ResCare Community Living to Sevita for $835M cash; expected close H2 2025, subject to regulatory approvals.
BrightSpring refinances $2.55B Term Loan B at SOFR+250, saving ~$19M annually
Refinanced $2.55 billion Term Loan B due Feb 2031; no additional debt incurred.
BrightSpring director Matthew D’Ambrosio resigns; no disagreement
Matthew D’Ambrosio resigned from BrightSpring board and committees effective Nov 12, 2024.
BrightSpring Q3 revenue up 29% to $2.9B; raises full-year guidance
Revenue $2,907M (+28.8% YoY); net loss narrowed to $9.0M from $130.1M.
Reed steps down as CLO after 20+ years, incl. 11 as CLO; serves as Senior Legal Counsel until Mar 31, 2025.
BrightSpring Health Services appoints Dr. Steve Miller to Board of Directors
Dr. Steve Miller appointed as Class II director on September 27, 2024; board expands from 7 to 8 members.
BrightSpring Q2 revenue up 26% to $2.73B, raises FY2024 guidance
Revenue $2.73B (+26% YoY); net income $19.4M vs $2.8M in Q2 2023.
BrightSpring Health acquires Haven Hospice assets for $30M in stock
Abode Hospice of Florida, a BTSG subsidiary, signs asset purchase agreement to acquire Haven Hospice (NCF Hospice) and Haven Medical Group.
BrightSpring Health Services adopts Senior Executive Cash Incentive Bonus Plan
Compensation Committee adopted the Bonus Plan on May 29, 2024 for key employees.
BrightSpring Q1 revenue up 27%, net loss $46M; raises FY 2024 guidance
Net revenue of $2.577B, up 27% YoY; adjusted EBITDA $131M, up 13.2%.
BrightSpring Health appoints Timothy A. Wicks to Board and Audit Committee
Board expanded from 6 to 7 directors; Wicks appointed Class I director effective April 24, 2024.
BrightSpring Q4 revenue $2.38B (+20.5%), net loss narrows to $7M; guides FY24 revenue $9.35-9.50B
Q4 revenue $2,375M (+20.5% YoY); gross profit $369M (15.5% of revenue).
BrightSpring closes $2.566B term loan refinancing, extends maturity to 2031
New $2.566B Tranche B-4 Term Loan priced at SOFR+3.25%, matures Feb 21, 2031.
BrightSpring Health Services (BTSG) IPO: 53.3M shares at $13, 8M Units at $50, net $1.05B
Net proceeds of $1,046.4M from IPO of 53,333,334 shares at $13.00 and 8,000,000 Units at $50.00.
appointed Dr. Nigam H. Shah to the Board as a Class III director to fill the resulting vacancy.
On June 20, 2025, Michael McMaude resigned as the President of Hospice Services of BrightSpring Health Services, Inc. (the “Company”), and the Chief Executive Officer of Abode Healthcare, Inc., a subsidiary of the Company (“Abode”), effective immediately
On April 11, 2025, the Committee approved that certain Severance Agreement, dated as of April 14, 2025, by and between Res-Care, Inc., an affiliate of the Company, and Mr. Mattingly (the “Severance Agreement”), pursuant to which Mr. Mattingly’s employment with the Company terminated on the Transition Date
Effective on March 4, 2025, Jennifer Phipps, the current Chief Accounting Officer of BrightSpring Health Services, Inc. (the “Company”), was promoted to Chief Financial Officer.
Ms. Phipps succeeds Jim Mattingly, whose transition and departure was not a result of any disagreement with the Company or any matter relating to the Company’s operations, policies or practices.
On November 12, 2024, Matthew D’Ambrosio resigned as a member of the board of directors (the “Board”) of BrightSpring Health Services, Inc. (the “Company”), the Compensation Committee of the Board, and the Quality, Compliance, and Governance Committee of the Board, effective as of November 12, 2024.
As of October 11, 2024, Steven S. Reed, the Chief Legal Officer and Corporate Secretary of BrightSpring Health Services, Inc. (the “Company”), has made the decision to retire from his position after over twenty years of service with the Company, first as a director, and the final eleven years as Chief Legal Officer.
On September 27, 2024, the board of directors (the “Board”) of BrightSpring Health Services, Inc. (the “Company”) increased the number of directors serving on the Board from seven (7) to eight (8) members and appointed Dr. Steve Miller to the Board as a Class II director to fill the resulting vacancy.
appointed Timothy A. Wicks to the Board as a Class I director
On January 25, 2024, effective immediately following the pricing of the Common Stock Offering, Olivia Kirtley was elected to serve as a new member of the Company’s Board, as the chair of the Audit Committee, and as a member of the Quality & Compliance and Governance Committee.
Max materiality 0.90 · Median 0.60 · Most common event earnings